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Enterovirus 71 (EV71) is a major pathogen that causes hand–foot–mouth disease (HFMD). Our previous
studies have demonstrated that the complete process of pathogenesis, which may include tissue
damage induced by host inﬂammatory responses and direct tissue damage caused by viral infection,
can be observed in the central nervous system (CNS) of animals infected in the laboratory with EV71.
Based on these observations, the neuropathogenesis and protein expression proﬁles in the thalamic
tissues of EV71-infected animals were further analyzed in the present study. Changes in protein
expression proﬁles following immunization with the inactivated EV71 vaccine followed by virus
challenge were observed and evaluated, and their physiological roles in viral pathogenesis are
discussed. Taken together, the results of these experiments provide evidence regarding the neuro-
pathogenesis and molecular mechanisms associated with EV71 infection and identify several protein
indicators of pathogenic changes during viral infection.
Crown Copyright & 2012 Published by Elsevier Inc. All rights reserved.Introduction
In recent years, studies on infectious diseases in children have
called attention to enterovirus 71 (EV71), which is the major
pathogen that causes hand–foot–mouth disease (HFMD) through-
out the world, especially in regions of Asia (McMinn, 2002; Ooi
et al., 2007). This focus is not only because of the recent HFMD
epidemics in mainland China and other locations in Asia (Chan
et al., 2000; Shimizu et al., 1999; Yang et al., 2009) but also
because of the fatal cases associated with EV71-induced neuro-
pathogenesis during these epidemics (Chen et al., 2007; Ho et al.,
1999; McMinn, 2002). At present, based on a preliminary patho-
logical study of clinical cases of EV71 infection (Wong et al.,
2008), a consensus has been reached that this viral infection
might cause serious pathological changes in the central nervous
system (CNS) of a small number of individuals. Infants are
especially at risk for developing CNS pathology that causes
neurogenic pulmonary edema, which is the major cause of death012 Published by Elsevier Inc. All
hinese Academy of Medicine
ling Road, Kunming, Yunnan
ually to this work.associated with HFMD (Hsueh et al., 2000; Lin et al., 2006; Wong
et al., 2008). However, due to a lack of adequate human clinical
pathological data, the pathological processes and mechanisms of
EV71 infection remain elusive (Huang et al., 2009). Therefore, it is
important to conduct further analyses of the pathogenesis of this
disease, especially its neuropathogenesis, from the histopathology
of infected organs to the molecular mechanisms of viral infection.
In previous studies by our group and others, pathological analyses
of EV71 infection in primates have revealed that the complete
process of EV71 pathogenesis can be observed in the CNS of
animals, such as cynomolgus monkeys and rhesus monkey
infants, that are infected with the virus in the laboratory (Liu
et al., 2011; Nagata et al., 2004; Zhang et al., 2011). Additionally,
some pathological and etiological indicators have demonstrated
that this infectious process can be validated (Liu et al., 2011;
Zhang et al., 2011). These results provide an understanding of the
pathological mechanisms underlying EV71 infection from a his-
tological perspective.
Based on the data obtained in these primate studies, it might be
possible to use these established animal models to evaluate EV71
vaccines or therapeutic drugs with respect to histopathology, immu-
nology and pharmacology (Liu et al., 2011). However, the indicators
obtained in previous studies are a general index and only show
changes in the histopathology, etiology and immunology associatedrights reserved.
H. Chen et al. / Virology 432 (2012) 417–426418with EV71 infection, which may not reﬂect the physical changes and
related molecular mechanisms involved in the process of infection.
The results from recent studies of severe HFMD cases caused by EV71
infection indicate that in addition to tissue damage directly caused by
viral infection of the CNS, tissue damage may also occur due to host
inﬂammatory responses (Lin et al., 2003; Wang et al., 2003; Wong
et al., 2008).
In our previous studies, experiments on EV71-infected rhesus
monkey neonates demonstrated that the virus can infect animals
via the respiratory tract and cause common clinical manifesta-
tions, including blister-like lesions on the oral mucosa and skin
(Liu et al., 2011). Additionally, an increase in the body tempera-
ture of these animals was accompanied by the emergence of
viremia and pathological changes in the CNS, among other effects
(Liu et al., 2011; Zhang et al., 2011). These pathological features
have been used to speciﬁcally evaluate the effectiveness of and
the protection provided by the inactivated EV71 vaccine (Dong
et al., 2011,2010). Based on the dynamic analysis of these
features, 2D protein electrophoresis was used to evaluate the
changes in protein expression in the thalamic tissues of rhesus
monkey neonates that were immunized with the inactivated
EV71 vaccine prior to viral challenge. Dynamic changes in protein
expression were observed in these animals in comparison with
the thalamic tissues from unimmunized animals that were
directly infected with the virus. Based on our interpretation of
the changes in the expression of these identiﬁed proteins, further
evaluation of the response of immunized animals to the challenge
with live virus was conducted in this study.Results
Pathological analysis of CNS tissues from neonatal monkeys in the VI
and UI groups
As previously demonstrated by pathological data from the fatal
human cases and animals infected with EV71, the majority of the
pathological lesions in the CNS induced by EV71 infection are found
in the thalamus, pons and spinal cord (Liu et al., 2011; Wong et al.,
2008; Zhang et al., 2011). The lesions observed in these regions could
contribute to neurogenic pulmonary edema (Lum et al., 1998).
Therefore, most of our work focused on the pathological features of
the tissues, speciﬁcally the thalamus, pons and spinal cord, to
observe the efﬁcacy of the inactivated EV71 vaccine and to ulti-
mately deﬁne these three sites as those potentially critical for the
evaluation of candidate vaccines (Dong et al., 2011). In our compara-
tive study, no signiﬁcant pathological changes were observed in the
VI group, except for a few cases of inﬂammatory cell inﬁltration in
some parts of the thalamus, pons and spinal cord. However, changes
were observed in the UI group, such as typical inﬂammatory cell
aggregation, vascular cufﬁng and a small amount of neuronal cell
degeneration and necrosis (Fig. 1). Similar pathological changes to
those observed in the thalamus, pons and spinal cord were also
observed during synchronized observations of other tissues of the
CNS and major organs (Fig. S1). These results are in accordance with
the previous work on other target organs (Dong et al., 2011).
Furthermore, the pathological changes were found to be most
pronounced on day 10 post-infection (p.i.) and began to disappear
slightly on day 14 p.i. (Fig. 1). These pathological changes might
therefore be used as deﬁned pathological markers of encephalitis.
Virus distribution in the CNS tissues of neonatal monkeys in the VI
and UI groups
Our previous studies on EV71-infected neonatal rhesus mon-
keys demonstrated that the highest viral loads were detectableduring days 7–10 p.i. in the main organs and tissues of the
monkeys (Liu et al., 2011), which might indicate that viral loads
in the organs and tissues may be used as indicators of EV71
infection. In this study, the viral loads in tissues of the CNS,
including cerebrospinal ﬂuid (CSF) collected from the VI and UI
groups, were measured to evaluate the ability of the inactivated
EV71 vaccine to protect the CNS of infected monkeys. The qRT-
PCR data and direct virus titers in tissue culture were similar. No
virus was detected in the CNS tissue samples collected from the VI
group (Fig. 2a). In contrast, peak viral titers were observed 10 day
p.i. in most tissues of the CNS, including the cerebrum, thalamus
and cerebellum, except in the CSF that was collected from the UI
group. The peak viral titer in the spinal cord was observed at day
7 p.i. and was maintained until day 10 p.i. (Fig. 2a). Furthermore,
qRT-PCR ampliﬁcation demonstrated that the viral RNA copies in
the samples from the VI group were lower than 100 (Fig. 2b). The
medulla oblongata from the UI group had higher than 106 viral
RNA copies (Fig. 2b), and the viral peak coincided with the viral
titers that were determined in tissue culture. These results and
previous reports (Liu et al., 2011; Nagata et al., 2004) indicate that
the CNS is a primary target organ of EV71 viral proliferation in
neonatal monkeys. Observations made using immunohistochem-
ical detection with EV71-speciﬁc antibodies in the various CNS
tissues further support these ﬁndings (Fig. S2). The viral loads
detected in the CNS of the samples from the VI group, which had
been immunized with the inactivated EV71 vaccine, clearly
indicate that the immune response induced by vaccination has
the capacity to inhibit viral proliferation in the CNS.The detection of antibodies and inﬂammatory factors in the
cerebrospinal ﬂuid of VI and UI monkeys
Clinical descriptions of fatal cases of EV71 infection have
suggested that the pathological lesions in the CNS can progress
rapidly to pulmonary edema and respiratory failure (Liu et al.,
2000; Nolan et al., 2003). This type of acute pathogenic progress
might be caused by a severe inﬂammatory reaction mechanism,
such as a ‘‘cytokine storm’’ (Lin et al., 2002; Wang et al., 2003). In
studies evaluating the efﬁcacy and safety of candidate EV71
vaccines, the levels of inﬂammatory factors are commonly con-
sidered to be one type of potential indicator, especially in the CSF
(Dong et al., 2011; Liu et al., 2011). However, based on reports
about antibody-dependent enhanced infection (ADE) by EV71
(Han et al., 2011; Wang et al., 2010) and antibody-mediated
cytotoxicity (Ch’ng et al., 2011), levels of speciﬁc antibodies
against EV71 in the cerebrospinal ﬂuid were measured, and the
titer was compared to that in peripheral blood. The results
demonstrated that the levels of the IL-2, IL-4, IL-5, IL-6, TNF-a
and IFN-g in the cerebrospinal ﬂuid of the monkeys in the VI
group did not increase signiﬁcantly or ﬂuctuate and were main-
tained within the normal range (Fig. 3a). In contrast, the levels of
the majority of these inﬂammatory factors, especially IL-6 and
TNF-a, tended to increase in the cerebrospinal ﬂuid of the
monkeys in the UI group, which was demonstrated by higher
observed levels of IL-6 during disease progression (Fig. 3). These
factors were sustained at levels that were signiﬁcantly higher
than normal from days 7 to 14 p.i. The highest values were
observed on day 10 and then gradually declined. However,
measurement of anti-EV71 antibodies using the neutralizing test
failed to detect antibodies in the cerebrospinal ﬂuid of either
group (Fig. S3). In contrast, an extensive increase in antibodies in
the peripheral blood of the VI group and a slight increase in the UI
group at the same time point were observed (Fig. S3). The higher
levels of cytokines in the cerebrospinal ﬂuid are similar to those
reported from the studies of other animals infected with EV71 as
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et al., 2006; Lin et al., 2002,2003).2D electrophoresis of the thalamic tissues of VI and UI
monkeys
To better understand the molecular biological features of the
pathological changes in the CNS induced by EV71 infection and to
link them to the mechanisms underlying the protective effect
generated by the inactivated EV71 vaccine, 2D electrophoresis
was performed to compare the thalamic tissues of the 3 neonatal
monkey groups. Before the ﬁrst phase of isoelectric focusing (IEF),
the loaded gel samples from these 3 groups were subjected
to total protein quantiﬁcation using the PlusOne 2D Quant kit.
An antibody to GAPDH was used for Western blotting as aFig. 1. Pathological changes in the thalamus, pons and spinal cord of vaccine-immunize
(VI), monkeys immunized with 160 EU of the inactivated vaccine were inoculated wit
monkeys were injected with PBS and inoculated with 104.5 TCID50/100 ml of EV71 (FY-2
tissue (thalamus, pons and spinal cord) sections were stained with hematoxylin and eo
100x (thalamus and spinal cord; bar, 60 mm) and 200x (pons; bar, 30 mm). The inﬁltrat
retrogression (yellow arrow) are shown. Samples were collected at day 10 and day 14
referred to the web version of this article).reference internal control and it displayed equal intensities when
analyzed using conventional processes (Fig. S4a). The 2D gels
were then analyzed using an image scanner (Epson EU-88) (Fig.
S4b). The spots of upregulated or downregulated protein mole-
cules were identiﬁed in the 2D gels of the samples taken from the
VI and UI groups based on the background of the UU group. After
the identiﬁcation of the protein spots by MALDI-TOF/TOF mass
spectrometry analysis, peptide scores less than 80 were regarded
as signiﬁcantly differentially expressed molecules (po0.05). In
total, the proﬁles of 47 regular protein molecules, not including
viral proteins, were obtained (Table S2). We identiﬁed changes in
the expression of 9 molecules involved in signal transduction,
8 cellular structure proteins, 13 molecules involved in cellular
metabolism, 4 macromolecular biosynthesis-related molecules,
10 molecules involved in energy metabolism and bio-oxidation,
2 molecules involved in the ubiquitin-proteasome pathway andd or unimmunized neonatal monkeys infected with EV71. In the vaccinated group
h 104.5 TCID50/100 ml of EV71 (FY-23 strain). In the unvaccinated group (UI), the
3 strain). The control group monkeys were uninfected and unimmunized (UU). The
sin (H&E) and imaged using an optical microscope with original magniﬁcations of
ion of inﬂammatory cells (black arrow), vascular cufﬁng (green arrow) and neuron
p.i. (For interpretation of the references to color in this ﬁgure legend, the reader is
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the VI and UI groups (Table S2).The protein expression proﬁle in the thalami of the VI and UI
monkeys
Prior to investigating the speciﬁc pathological features in the
thalami of neonatal monkeys infected with EV71, we further
explored the expression proﬁles of proteins identiﬁed in several
functional groups that may have been potentially generated by
these pathological features. The results demonstrated a 1- to
5-fold ﬂuctuation in the levels of the majority of the molecules,
and values greater than 5-fold were observed for some individual
molecules (Fig. 4a). Among the signal transmission molecules that
are closely correlated with viral infection, the expression level of
neuronal protein NP2 (TAGLN3, a member of the calmodulin
protein family) was upregulated in the thalami of UI monkeys at
day 10 p.i. and returned to normal levels at day 14 p.i. (Fig. 4b).
Conversely, the expression proﬁle of this protein was unchanged
in the VI group (Fig. 4b). The expression proﬁle of another protein,
galectin-1 (LGALS1, a member of the galactosidase-binding pro-
tein family), was normal in the thalami of UI monkeys at day 10
p.i. and was downregulated at day 14 p.i. However, galectin-1
levels were downregulated in the VI group at day 10 and day 14
p.i. (Fig. 4b).
With respect to the proteins associated with cellular struc-
tures, the expression proﬁle of the stathmin-like protein (STMN1,
a member of the microtubule-associated protein family) was
upregulated in the UI group at day 10 p.i. and downregulated at
day 14 p.i., whereas it was downregulated in the VI group day 10
and day 14 p.i. (Fig. 4c). Interestingly, the expression level of
ubiquitin carboxyl terminal hydrolase (UCHL1) doubled in the UI
group at day 10 and day 14 p.i. but increased slightly in the VIFig. 2. Dynamic viral distribution in CNS of vaccine-immunized or unimmunized monk
vaccinated (VI) and unvaccinated (UI) groups. Viral titer was measured using a microt
section. (b) RT-PCR ampliﬁcation of viral copies in the vaccinated (VI) and unvaccinated
spectrophotometry, and the quantity was expressed as a relative copy number, which w
number¼viral copy number/ml. Tissue specimens were collected from organs of the ani
for 2 samples at each time point.group at day 10 p.i. and was clearly downregulated below normal
control levels at day 14 p.i. (Fig. 4g). Notably, the expression
proﬁle of the diazepam-binding inhibitory protein (DBI, also
known as benzodiazepine receptor inhibitory peptide or acyl-
coenzyme A-binding protein) was upregulated by more than
3-fold in the UI group at day 10 and day 14 p.i. but was at normal
levels in the VI group at the same time points (Fig. 4d). Similar
expression proﬁles were found for the other functional groups
(Fig. 4).
Quantiﬁcation of protein transcript levels by RT-PCR
To quantify the transcript levels of the above proteins in the
thalami of monkeys in the VI and UI groups, RT-PCR was
performed using primers designed based on the mRNA sequences
of 2–3 genes that encode proteins in each functional group.
A total of 18 genes, including the PARK7 and TAGLN3 genes from
the group of signal transmission variations and the GMFB, STMN1
and MAP1B genes from the cellular structure protein group, were
selected for primer design. The RNA extracted from the thalamic
tissues from each monkey group was used as template. The
results are shown in Fig. 5. The transcript levels quantiﬁed by
RT-PCR ampliﬁcation had the same tendency as those observed in
the thalami of the UU monkeys (Fig. 5), which conﬁrms the
results from our 2D electrophoresis analysis.Discussion
In studies analyzing fatal cases of human EV71 infection and
viral animal models, the mechanisms underlying the pathogenic
process, which is frequently characterized by pathological
changes in the CNS and partial lung failure correlated with
encephalitis, remain to be elucidated (Kung et al., 2007; Lineys that were infected with EV71. (a) Titration of the virus in the CNS tissues of the
itration assay according to the procedure described in the Materials and Methods
(UI) groups. Viral copies were quantiﬁed according to in vitro-synthesized RNA by
as determined by the equation [(mg of RNA/ml)/(molecular weight)]Avogadro’s
mals in the groups described above on days 4, 7, 10 and 14 p.i. Values are the mean
Fig. 3. Inﬂammatory cytokines in the cerebrospinal ﬂuid of the vaccine-immunized or unimmunized neonatal monkeys that were infected with EV71. In the vaccinated
group (VI), monkeys immunized with 160 EU of inactivated vaccine were inoculated with 104.5 TCID50/100 ml of EV71 (FY-23 strain). In the unvaccinated group (UI),
monkeys were injected with PBS and inoculated with 104.5 TCID50/100 ml of EV71 (FY-23 strain). The concentrations of the proinﬂammatory cytokines (IL-2, IL-4, IL-5, IL-6,
TNF-a and IFN-g) were analyzed according to the procedure described in the Materials and Methods section. The normal ranges (data collected from two monkeys from
the uninfected and unimmunized (UU) group) are shown as a dotted line. npo0.05 indicates a signiﬁcant difference between the UI group and VI group at the same time
point. nnpo0.01 indicates remarkable signiﬁcance.
H. Chen et al. / Virology 432 (2012) 417–426 421et al., 2002). Infection-induced pathological changes remain the
predominant cause of death associated with HFMD in infants and
young children infected with EV71 (Huang et al., 2006;
Zimmerman, 1999). Theoretically, the potential reasons include
tissue damage resulting from viral proliferation, a pathological
immune response or ‘‘cytokine storm’’ inﬂammatory reaction
induced by viral infection, or other unknown reasons (Lin et al.,
2002; Wang et al., 2003). Therefore, investigation and character-
ization of the mechanisms that cause pathological changes in the
CNS during EV71 infection would not only provide an under-
standing of the pathogenesis of EV71 infection but, more impor-
tantly, would also provide detailed criteria for evaluating the
efﬁcacy of inactivated EV71 vaccine candidates based on an
understanding of the characteristics of the pathological changes.
Therefore, our studies highlight important pathological changes
in the CNS of EV71-infected neonatal monkeys, including
dynamic proﬁles of virus distribution and proliferation as well
as host inﬂammatory reaction status. Additionally, we deter-
mined whether the immune response induced by the inactivated
EV71 vaccine has the capacity to protect tissues in the CNS from
damage caused by viral infection and inﬂammatory reactions.
Additionally, to determine the molecular mechanisms underlying
neuropathological changes induced by EV71 infection and the
potential for evaluating candidate inactivated EV71 vaccines, the
protein expression proﬁles in the thalami from EV71-infected and
vaccine-immunized monkeys were analyzed using a 2D protein
assay. The molecular features of EV71 pathogenesis that are
described here represent preliminary data that provide insight
into the details of the protection conferred by immunization.
The clinical pathological examination of fatal cases of EV71
infection shows the features typical of an inﬂammatory reaction
(Wong et al., 2008). In our previous work, we described similar
histopathological changes, which are frequently found in the CNS
of EV71-infected neonatal monkeys in the thalamus, pons and
medulla oblongata as well as part of the cerebrum and spinal cord(Fig. 1). The distribution and variety of such pathological changes
may correlate with virus distribution and proliferation (Fig. 2)
(Liu et al., 2011). Such a correlation suggests that a biological
feature of viral infection may elicit direct pathological changes in
the CNS. In parallel, the fact that we failed to detect the typical
pathological changes and an absence of virus in the CNS of
inactivated EV71 vaccine-immunized monkeys (Figs. 1 and 2)
supports the above conclusion and demonstrates the efﬁcacy of
our candidate vaccine. Additionally, the analysis of the cerebrosp-
inal ﬂuid from EV71-infected monkeys indicates that the levels of
the associated cytokines, such as IL-6, IFN-g and TNF-a, tend to
increase throughout the infectious process (Fig. 3), which is
consistent with the reports on EV71 infection in humans (Lin
et al., 2002). However, the cause of the pathological changes in
the CNS requires further clariﬁcation. The normal levels of
cytokines in the cerebrospinal ﬂuid of vaccine-immunized mon-
keys support the efﬁcacy of our candidate vaccine. In addition,
this study failed to detect EV71-neutralizing antibodies in the
cerebrospinal ﬂuid of EV71-infected monkeys and vaccine-immu-
nized monkeys (Fig. S3), which implies a lack of ADE in the CNS of
EV71-infected and vaccine-immunized monkeys. Nevertheless,
these results are not sufﬁcient to determine the cause of EV71-
mediated pathogenesis and the molecular mechanism of the
candidate vaccine.
Our study further compared the protein expression proﬁles of
thalamic tissues of EV71-infected and vaccine-immunized mon-
keys using a 2D protein assay. The results demonstrated that the
pathogenic process was associated with altered expression pro-
ﬁles of at least 47 proteins (Table S2), and the proﬁles of these
proteins might have speciﬁc signiﬁcance. For example, the highly
conserved PARK7 protein, which interacts with PIAS (protein
inhibitor of activated STAT, a member of the SUMO-1 ligase
family), is encoded by the dj-1 gene and was identiﬁed in the
group of molecules that regulate transcription (Takahashi et al.,
2001). PARK7, in association with other proteins such as p54nrb,
Fig. 4. Protein expression proﬁle in the thalami of vaccine-immunized or unimmunized neonatal monkeys infected with EV71. (a) Proteins exhibiting a change in
expression levels in the thalamic tissues of vaccine-immunized (VI), unimmunized (UI) and normal (UU, uninfected and unimmunized) neonatal monkeys. Monkeys in the
VI group were immunized with 160 EU of inactivated vaccine and inoculated with 104.5 TCID50/100 ml of EV71 (FY-23 strain). Monkeys in the UI group were injected with
PBS and inoculated with 104.5 TCID50/100 ml of EV71 (FY-23 strain). A matrix of 47 proteins at days 10 and 14 p.i, as analyzed using the Resolver analysis system (Rosetta
Biosoftware, Seattle, WA, USA), is shown. The fold change in expression levels is relative to the vaccinated/unvaccinated/normal samples and is displayed in red (increased
expression) or green (decreased expression). The number in the top left corner indicates the representative cluster. (b–h) The fold change in the expression of proteins
within individual clusters. The dotted line indicates no change in expression (Y¼0). (b) Cluster 1, signal transduction proteins. (c) Cluster 2, cellular structural proteins.
(d) Cluster 3, cellular metabolism-related proteins. (e) Cluster 4, macromolecular biosynthesis-related proteins. (f) Cluster 5, energy metabolism and bio-oxidation-related
proteins. (g) Cluster 6, ubiquitin-proteasome pathway-related proteins. (h) Cluster 7, stress response proteins. (For interpretation of the references to color in this ﬁgure
legend, the reader is referred to the web version of this article).
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stress and necrocytosis resulting from mutations in a-synuclein
(Abou-Sleiman et al., 2006). Mutation of this protein is associated
with Parkinson’s disease, which suggests that the protein may
exert functional protection on the neuronal cells in the CNS in
response to viral infection (Bandopadhyay et al., 2004; Inden
et al., 2006; Yanagida et al., 2006). This conclusion is supported by
the observed upregulation of this protein in the thalamic tissues
of EV71-infected animals. In contrast, the slight upregulation of
PARK7 in the thalami of VI animals most likely indicates that the
vaccine can effectively prevent pathological damage to neuronal
cells upon viral infection (Fig. 4). This result is consistent with the
data regarding NP25 (TAGLN3) and galectin-1 (LGALS1), which
function positively in the transcriptional regulation of neuronal
cell proliferation, differentiation and restoration (Camby et al.,
2006; Ren et al., 1994) (Fig. 4). Additionally, the expression
proﬁles of other proteins associated with the maintenance and
recovery of neuronal cell function were found to have a similar
tendency. For example, ubiquitin carboxyl-terminal hydrolase 1(UCHL1) plays a major role in the maintenance of the normal
function of neurons at the cellular level via binding to mono-
ubiquitin in neurons (Liu et al., 2002). The upregulated expression
of UCHL1 and DBI observed in the thalamic tissues of UI monkeys
may indicate a protective effect on neuronal cells in response to
viral infection, whereas the normal expression of UCHL1 and DBI
(Table S2) in the thalami of the VI monkeys further emphasized
the protective effect induced by immunization.
Additionally, the upregulation of enzymes associated with
cellular metabolism in the UI monkeys and their downregulation
in the VI monkeys indicate that the pathological and physiological
effects observed in the CNS of EV71 infected animals should not
be solely attributed to the histopathological lesions generated by
viral replication. In fact, upregulated expression of another
speciﬁc protein, cyclophilin A, in the UI monkeys (Table S2,
Fig. 4) suggests that the inﬂammatory response to viral infection
is likely directly linked to the histopathological lesions in the CNS.
The primary drug target of phosphoamidase repression, cyclophi-
lin A, is an essential molecule that generates granulocyte,
Fig. 5. Gene expression in the thalami of vaccine-immunized or unimmunized neonatal monkeys following infection with EV71. Real-time RT-PCR analysis of 18 selected
genes expressed in the thalami of the vaccine-immunized or unimmunized neonatal monkeys at days 10 and 14 p.i. with EV71 strain FY-23. The results were normalized to
the level of endogenous GAPDH. The y-axis indicates the relative quantity of the speciﬁc mRNA in the samples compared with the normal samples (UU monkeys, y¼0).
Error bars indicate the SD of the relative quantities. npo0.05 indicates a signiﬁcant difference between the UI group and VI group at the same time point. nnpo0.01
indicates remarkable signiﬁcance. Cluster 1, signal transduction proteins (PARKT, TAGLN3, DDAH2). Cluster 2, cellular structural proteins (GMFB, STMN1, MAP1B). Cluster 3,
cellular metabolism-related proteins (PGAM1, FABP5, DBI, DPYSL3, PHPT1). Cluster 4, macromolecular biosynthesis-related proteins (APRT, GABARAPL2). Cluster 5, energy
metabolism and bio-oxidation-related proteins (HBA1, HSD17B10). Cluster 6, ubiquitin-proteasome pathway-related proteins (UCHL1, UBE2N). Cluster 7, stress response
proteins (CRYAB).
H. Chen et al. / Virology 432 (2012) 417–426 423eosinocyte and monocyte chemotaxis in response to inﬂamma-
tory reactions (Arora et al., 2005). Based on the above mentioned
speculation, the speciﬁc biological features of cyclophilin A and
the upregulated expression of inﬂammatory factors in the cere-
brospinal ﬂuid, especially IL-6 and TNF-a (Fig. 3), it is reasonable
to conclude that the inﬂammatory reactions associated with EV71
infection might cause the histopathological lesions in the CNS to
some extent. This model is further supported by the normalexpression levels of cyclophilin A in vaccine-immunized neonatal
monkeys.
In summary, based on the above data and, in particular, the
molecular biological features of these differentially expressed
proteins, we hypothesize that the immune response induced by
the inactivated EV71 vaccine could repress the histopathological
effects in the CNS and subsequently reduce the inﬂammatory
damage to cells. Similarly, the data also indicate that the
H. Chen et al. / Virology 432 (2012) 417–426424histopathological lesions in the CNS that were previously
reported to be induced by EV71 infection are correlated with
inﬂammatory reactions as well as direct viral infection.Competing interests
The authors declare that they have no competing interests.Materials and methods
Viruses and cells
The EV71 virus strain FY-23 was used in this study; it was
isolated from hematic secretions from the respiratory tract of an
infected male child who presented with clinical symptoms of
severe cardiopulmonary collapse during an epidemic in Fuyang,
China, in May 2008 (GenBank accession number: EU812515.1)
(Ma et al., 2009). Using RT-PCR, the strain was identiﬁed as an
EV71 C4 sub-genotype virus prior to Vero cell inoculation (Zhang
et al., 2011). The viruses that were grown in Vero cells were
harvested and frozen at 20 1C when the typical cytopathic
effects developed and when the virus reached a concentration
of 107.0–107.5 cell culture infectious doses (CCID50)/ml. Human
diploid cells (KMB-17, human embryo lung cell) were maintained
in DMEM (Hyclone, Logan, UT, USA) with 5% foetal bovine serum
(Gibco, Grand Island, NY, USA) and grown to a conﬂuent mono-
layer (Dong et al., 2010; Guo et al., 1981; Yang et al., 2006). Vero
cells were maintained in DMEM with 5% foetal bovine serum.Virus titration and neutralisation assay
EV71 virus that had been harvested from cell culture or
isolated from different organs and tissues of infected newborn
rhesus monkeys were analysed by performing a microtitration
assay using a standard protocol (Arita et al., 2006). The neutra-
lisation test for the virus was performed as previously described
(Liu et al., 2011).Inactivated EV71 virus vaccines
The FY-23KB viral clone was obtained from the FY-23 strain
through passaging 5 times and twice plaque selecting in human
diploid cell (KMB-17 strain) (Dong et al., 2010). After identiﬁca-
tion and characterisation of the strain using biological, genetic
and immunological analyses, aliquots of EV71 and FY-23KB were
inoculated into KMB-17 monolayer cells as previously described
(Dong et al., 2011). Brieﬂy, the harvested viruses were centrifuged
and inactivated with 1/4000 formalin before incubation at 37 1C
for 96 h. The viruses were subsequently sampled at 4-h intervals.
After inactivation, the virus was concentrated 200-fold by ultra-
ﬁltration (QuixStand Benchtop System, GE Healthcare, Milwau-
kee, WI, USA). Puriﬁcation was performed on a Sepharose 6-FF
column (GE Healthcare, Milwaukee, WI, USA). The puriﬁed
inactivated virus was used to measure antigen content via an
enzyme-linked immunosorbent assay (ELISA) (Xie et al., 2010).
A solution of the inactivated virus was then emulsiﬁed in 1 mg/
ml Al(OH)3 adjuvant, which constituted the ﬁnal vaccine. All of
the vaccine samples were released for follow-up investigations
after a quality control evaluation had been performed. The
evaluation included an examination of the efﬁciency of viral
inactivation and the vaccine antigen content.Neonatal rhesus monkeys
The animal work was conducted according to relevant national
and international guidelines. In accordance with the recommen-
dations of the Weatherall report, ‘‘The use of non-human pri-
mates in research’’, the following section includes the details of
the animals’ welfare and the steps that were taken to ameliorate
suffering in all work involving non-human primates. The Ofﬁce of
Laboratory Animal Management of Yunnan Province, China,
approved the experimental procedures that were performed on
the animals (approval number: SCXK (Dian) 2005-0005). A total
of 10 1.5-month-old neonatal rhesus monkeys, 5 males and
5 females, were divided into the following 3 groups: 4 monkeys
were given the vaccine-immunisation followed by a virus chal-
lenge (immunised and infected, VI), 4 monkeys were directly
challenged with the virus as a control group (unimmunised and
infected, UI), and 2 monkeys were used as normal control group
(unimmunised and uninfected, UU). Each newborn monkey was
maintained in a single cage with its mother and fed according to
the guidelines established by the Committee of Experimental
Animals at the Institute of Medical Biology, Chinese Academy of
Medical Sciences (CAMS) (Gorska, 2000). All animals were held in
isolation for 2 weeks before the initiation of the study. The
inactivated EV71 vaccine (prepared from KMB-17 cells; 160 EU/
dose, EU: ELISA unit (Xie et al., 2010)) was inoculated intramus-
cularly into the right hind leg of neonatal rhesus monkeys at
weeks 0 (to immunise) and 4 (to boost).
The infection of neonatal rhesus monkeys
The monkeys in the VI and UI groups were challenged with the
live virus from the FY-23 strain (104.5 CCID50/dose) with an
aerosol formulation via the respiratory tract 4 weeks after boosting
(Liu et al., 2011). The monkeys in the UU group were treated with
phosphate-buffered saline (PBS). The monkeys were examined daily
for clinical manifestations. We collected 0.5 ml of cerebrospinal ﬂuid
from the anesthetised monkeys on days 0, 4, 7, 10 and 14. Two
monkeys in each group were euthanised on days 10 and 14 for
histopathological, biochemical and etiological examinations of var-
ious organs and tissues (Liu et al., 2011). Fresh thalamus tissues
were obtained and washed with PBS to remove the blood.
Biochemical tests of the cerebrospinal ﬂuids
To obtain CSF samples, the monkeys were anesthetised with
ketamine hydrochloride (15 mg/kg), and a 0.5-ml sample of CSF
was collected from each monkey by lumbar puncture within
25 min of the ketamine injection using a 1-cc syringe. The
samples were centrifuged at 1000 g at 4 1C within 1 h to remove
the cells and stored at 80 1C until further use. The concentra-
tions of the proinﬂammatory cytokines (IL-2, IL-4, IL-5, IL-6, TNF-
a and IFN-g) were analysed using an ELISA kit (BD Biosciences,
San Diego, CA, USA) according to the manufacturer’s instructions.
The absorbance was measured with a microplate reader (BioTek
Synergy 4, BioTek Instruments, Winooski, VT, USA).
Histopathological and immunohistochemical analysis
The tissue samples from the infected monkeys were ﬁxed in
10% formalin, dehydrated through ethanol gradients and
embedded in parafﬁn, as previously described (Liu et al., 2011).
For histopathological analysis, 4-mm sections were cut for hema-
toxylin and eosin (H&E) staining. For the immunohistochemical
analysis, 4-mm sections were cut for the antigen–antibody reac-
tion, as described previously (Liu et al., 2011). The EV71 antigen
was detected by mouse anti-enterovirus 71 monoclonal Antibody
H. Chen et al. / Virology 432 (2012) 417–426 425(Clone 10F0, Abcam, U.S.) and horseradish peroxidase (HRP)-
conjugated anti-mouse IgG antibodies (Sigma, Deisenhofen, Ger-
many). The analysis of the tissue sections was performed using an
optical microscope (Nikon, Tokyo, Japan).
2D protein electrophoresis analysis
The tissue samples were subjected to repeated freeze–thaw
cycles and then resuspended in 2D lysis buffer (8 M urea, 2 M
thiourea, 4% CHAPS, 100 mM DTT, 2% IPG buffer). Quantiﬁcation
of total protein was performed using the PlusOne 2D Quant kit
(GE Healthcare Europe GmbH, Freiburg, Germany) according to
the manufacturer’s instructions. Approximately 200 mg of protein
was precipitated according to the Wessel–Flu¨gge method (Wessel
and Flugge, 1984) and resuspended in 200 ml rehydration buffer
(8 M urea, 2 M thiourea, 2% CHAPS, 100 mM DTT, 2% IPG buffer).
The resuspended proteins were ﬁrst separated based on their pI
using 24 cm immobilised linear gradient strips (ImmobilineTM
DryStrip, Amersham Biosciences Europe GmbH, Freiburg, Ger-
many) covering a pH range of 3–10. The strips were rehydrated
for 12 h and subsequently subjected to the following high
voltages at 20 1C for electric focusing: 100 V for 5 h, a 500 V
gradient for 1 h, a 1000 V gradient for 1 h, an 8000 V gradient for 2 h
and an 8000 V to a total of 60,000 Vh. After equilibrating for 20 min
in equilibration buffer (6 M urea, 30% glycerin, 2% SDS, 50 mM Tris
pH 8.8, 100 mM DTT) and alkylation for an additional 20 min in the
same solution containing 250 mM iodoacetamide, the proteins were
separated by 12% SDS-PAGE. The spots were visualised using mass
spec-compatible silver staining. To conﬁrm the reproducibility and
exclude the experimental variations in the 2D-PAGE assays and to
detect the qualitative and quantitative changes in the obtained
protein spots, the experiments were repeated three times.Mass spectrometry analysis
The protein patterns on the gels were recorded as digitalised
images using a high-resolution scanner (ImageScanner III EU-88,
GE Healthcare, USA). The scanned images were analysed using
Image Master 2D Platinum 7.0 software (GE Healthcare, USA). The
differentially expressed proteins identiﬁed in each thalamus
sample were compared to the normal thalamus samples (UU
group). The protein spots of interest were excised from the silver-
stained 2D gels using an Ettan Spot Picker (GE Healthcare, Fair-
ﬁeld, USA). The proteins were destained with destaining solution
containing 15 mM K3Fe(CN)6 and 50 mM NaS2O3. Subsequently,
the proteins were digested with trypsin, which cleaves peptides
on the carboxylic side of the arginine and lysine residues.
Following digestion, the tryptic peptides were extracted from
the gel pieces with 50% acetonitrile/0.1% TFA, concentrated nearly
to dryness in a SpeedVac vacuum centrifuge and diluted to a total
volume of 5 ml with 1% TFA. The 1 ml aliquots of the samples were
analysed using the 4800 Plus MALDI-TOF/TOF system (matrix-
assisted laser desorption ionisation tandem time-of-ﬂight;
Applied Biosystems, Foster City, CA, USA). The positive ion mode
was used to automatically collect data with a PMF scan extent of
800–3500 Da. The obtained MS and MS/MS spectra data were
integrated and subjected to searches against the NCBInr-human
database using the GPS 3.6 (Applied Biosystems, Foster City, CA,
USA) and Mascot 2.1 (Matrix Science, http://www.matrixscience.
com) databases. The algorithm was set to use trypsin as the
enzyme, which permits a maximum of one missed cleavage site
as well as assumes that carbamidomethyl is a ﬁxed modiﬁcation
of cysteine and oxidised methionine and that the deamidation of
asparagine and glutamine are variable modiﬁcations. The mass
tolerance was set to 0.15 Da for MS and 0.25 Da for MS/MS.Western blotting
The protein samples were separated by SDS-PAGE and trans-
ferred to polyvinylidene diﬂuoride membranes (PVDF; Millipore
Corporation, Bedford, MA, USA). Western blot analysis was per-
formed using standard procedures (Shaw et al., 1992). Monoclonal
antibodies recognising GAPDHwere obtained from Sigma (Sigma, St.
Louis, MO, USA).
Extraction of total RNA and quantitative RT-PCR ampliﬁcation
Total RNA was extracted from fresh tissue homogenate from
the experimental animals using a Qiagen RNeasy Mini Kit accord-
ing to the manufacturer’s protocol (Qiagen, Hilden, Germany). The
differential expression of 18 genes, which were selected based on
the 2D gel electrophoresis analysis, was validated by real-time
quantitative RT-PCR using SYBR Green-based detection (Table S1).
The total RNA was eluted in a ﬁnal volume of 20 ml. For
quantiﬁcation, a single-tube RT-PCR assay was performed using
the TaqMan 1-step RT-PCR Master Mix in a 7500 Fast Real-time
RT-PCR system (Applied Biosystems, Foster City, CA, USA). The
following protocol was used for all PCR assays: 5 min at 42 1C and
10 s at 95 1C, followed by 40 cycles at 95 1C for 5 s and 60 1C for
30 s. The transcript of the conserved housekeeping gene GAPDH
was used to normalise the samples because its expression level is
relatively constant.
Statistical analysis
The data are expressed as the mean and the standard devia-
tion. The statistical signiﬁcance between the treatment groups
was calculated using a two-way ANOVA (GraphPad Prism. Graph-
Pad Software, San Diego, CA, USA), and a P value of o0.05 was
considered to be signiﬁcant.Acknowledgments
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